Find a Top Internist Near Me in Phoenix, AZ – Book an Appointment Instantly

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

About Ashim Aggarwal, MD, FRCP (London), FACC, FSCAI, FASE

Ashim Aggarwal, MD, FRCP (London), FACC, FSCAI, FASE, is board certified in general cardiology, echocardiography, nuclear medicine, and interventional cardiology. Dr. Aggarwal joined Cardiac Care Consultants in Peoria, Glendale, and Sun City West, Arizona, in 2018. 

He specializes in complex coronary interventions, including Impella LVAD support and percutaneous structural heart disease treatment, transcatheter aortic valve replacement (TAVR) for aortic stenosis, MitralClip™ therapy for severe mitral regurgitation, CardioMEMS™ HF System, Watchman™ implantation, and PFO Closures. 

Dr. Aggarwal went to medical school at KMC Mangalore (Manipal University) in India. He then finished his residency and obtained the prestigious MRCP (MD equivalent) from the Royal College of London in the United Kingdom. He then relocated to the United States and completed his internal medicine residency at Unity Health System, affiliated with the University of Rochester in New York. 

Afterward, he completed an advanced heart failure/cardiac transplant fellowship from Advocate Christ Medical Center, affiliated with the University of Illinois. Dr. Aggarwal did his general cardiology fellowship at the University of Illinois College of Medicine at Peoria, where he was appointed a Chief Cardiology Fellow. He then completed his interventional cardiology fellowship at the University of Utah in Salt Lake City. 

Dr. Aggarwal has published extensively and has authored multiple articles/manuscripts in many prestigious peer-reviewed journals. He has also presented abstracts and oral presentations at all major national and international cardiology conferences. 

Dr. Aggarwal is an External Examiner for Residency/Fellows training programs in the United Kingdom. He was also nominated in the prestigious Top Doctors 2021.

Jeffrey Pakula, DO, FACC, is board-certified in internal medicine and cardiology. He provides a wide range of cardiology services at Cardiac Care Consultants in Peoria, and Sun City West, Arizona. Dr. Pakula has been practicing medicine in Arizona since 1997 and joined Cardiac Care Consultants in 2001. He specializes in coronary artery disease and heart failure.

Dr. Pakula received his medical degree from Kansas City University in Missouri. He completed his internal medicine training at the University of Illinois and received his cardiology fellowship at the University of Health Sciences at the Chicago Medical School in Illinois. After completing his fellowship, he served as the Director of Medical Education at John H. Stroger Jr. Hospital of Cook County in Chicago, Illinois. 

Dr. Pakula welcomes both new and existing patients to Cardiac Care Consultants and is excited to be a part of their health care journey. To schedule an appointment with Dr. Pakula, call the office or book a consultation online

Charanjit Kapoor, MD, FACC, is board-certified in general, nuclear, and interventional cardiology. Dr. Kapoor has been practicing medicine since 2000 and joined Cardiac Care Consultants in Peoria, Glendale, and Sun City West, Arizona, in 2010. He specializes in coronary artery disease, heart failure, pacemaker implants, and loop implants.

Dr. Kapoor received his medical degree from Government Medical College in Patiala, India. He completed his internship and residency at Maricopa Medical Center in Phoenix, where he was appointed chief medical resident. Dr. Kapoor received his advanced heart failure, cardiac transplantation, and cardiology fellowship training at the Ochsner Clinic and Medical Foundation in New Orleans. 

After completing his fellowship, Dr. Kapoor completed an interventional cardiology fellowship at Brown University in Providence, Rhode Island. He is board certified by the American Board of Internal Medicine and the American Board of Cardiovascular Disease.

Dr. Kapoor looks forward to welcoming new patients to Cardiac Care Consultants and being a part of their health care team. Schedule an appointment by calling the office or booking online.

Vijay Swarup, MD, FACC, FHRS, is one of the physicians at Arizona Heart Rhythm Center, which has locations in Phoenix, Peoria, Gilbert, and Prescott, Arizona. He has been practicing clinical cardiac electrophysiology in Arizona since 2002. Before joining the practice, he completed a fellowship in clinical cardiac electrophysiology at the University of Chicago Hospitals and Loyola University Medical Center in Chicago, Illinois.

Dr. Swarup earned his bachelor's and medical degrees at the University of Delhi in New Delhi. He continued his education at St. Louis University School of Medicine, completing an internal medicine residency and a research fellowship in molecular cardiology. He completed a Cardiovascular Disease fellowship at the Thomas Jefferson University Hospital in Philadelphia. He then pursued a clinical cardiac electrophysiology fellowship at the University of Chicago Hospitals and Loyola University Medical Center in Chicago, Illinois.

Dr. Swarup has received specialized training in performing complex arrhythmia treatments, including trans-catheter ablations. He has a special interest in three-dimensional electroanatomical mapping techniques, left atrial appendage occlusion techniques, and ablative therapies for atrial fibrillation and ventricular tachycardia.

In Arizona, Dr. Swarup was among the first to perform epicardial and endocardial 3D mapping guided ablation of ischemic ventricular tachycardias, open irrigated ablations, robotic catheter ablations for arrhythmias, and implantation to left atrial appendage occlusion devices. Dr. Swarup has some of the most extensive experience in AF and VT ablations and implantation of LAA occlusion devices in the country. Dr. Swarup is also an active researcher of new ablation techniques, having authored numerous abstracts and manuscripts. He has been the principal investigator in many research protocols investigating promising new ablation techniques and devices for the treatment of arrhythmias.

Dr. Swarup is board certified in cardiovascular diseases and clinical cardiac electrophysiology.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Mohammad Nasser, MD, founder of Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona, is a board-certified internal medicine physician and population health specialist. Dr. Nasser has a special interest in complex patient care, gaining extensive experience as a hospitalist and internist providing care in hospitals, long-term acute care centers, and subacute rehabilitation.

With a well-known reputation as an exceptional health care innovator, Dr. Nasser creates and implements programs that improve the quality of care and diminish costs for hospitals and skilled nursing facilities.

Born and raised in Michigan, Dr. Nasser received his bachelor’s degree from Wayne State University in Detroit Michigan. After receiving his medical degree at the American University of the Caribbean School of Medicine in Sint Maarten, he completed his internship and internal medicine residency at Ascension Providence Hospital, Michigan State University College of Human Medicine in Grand Rapids, Michigan.

Dr. Nasser is known for numerous accomplishments in his field. He was the medical director at Arkos Health and managed more than 200,000 patients through his transitional care management program. 

During his tenure at Arkos Health, Dr. Nasser developed an inpatient program that shortened hospital stays and mobilized patients to the next level of care. He also implemented a skilled nursing program that improved the post-discharge process.

As a respected author, Dr. Nasser published articles in medical journals as well as the well-known book, “Management of Chronic Kidney Disease.” He also served as a manuscript reviewer for medical journals, including the Journal of the American College of Cardiology.

Dr. Nasser is a proud member of the Phoenix community, where he welcomes patients and is highly regarded for his quality of care and leadership roles.

Board-certified internal medicine physician, William Nassour, MD, provides integrative health care at Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona. His expertise includes all aspects of adult health care, however, he has a special interest in cardiovascular disease, diabetes, geriatrics, and post-acute care.

Dr. Nassour is well-respected for go-to advice, with peers seeking his assistance and guidance in geriatrics and post-acute care, and patients depending on his understanding to provide honest evaluations and recommend individualized care.

Dr. Nassour received his medical degree from Tishreen University in Latakia, Syria, and completed his residency training in internal medicine at the New York University Langone Health in Brooklyn, New York.

With more than a decade of experience as a practicing physician in hospital medicine, including outpatient and subacute care, Dr. Nassour has developed extensive knowledge and skills that help him better understand each patient and create effective treatment plans. 

He has successfully filled leadership roles as the medical director in different medical settings. He also remains active on various hospital committees.

Dr. Nassour welcomes new and current patients at Leading MDs, where he collaborates with each person to improve their health and well-being.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Leon Thompson, DO, is an experienced internal medicine physician at Thompson Medical Group in Peoria, Arizona. He provides comprehensive care to adults of all ages living with conditions ranging from heart disease and diabetes to memory loss. He supports people with personalized chronic disease management and weight management programs.

Dr. Thompson is a native of Arizona. He attended St. Matthew Catholic School in Phoenix, Arizona, and graduated from St. Mary’s Catholic High School, also in Phoenix. Dr. Thompson completed his undergraduate studies at Arizona State University in Phoenix and attended medical school at the Western University of Health Sciences, College of Osteopathic Medicine of the Pacific in Pomona, California.

After graduating with a Doctorate in Osteopathic Medicine, Dr. Thompson completed his internship and residency at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. He completed an American College of Osteopathic Internists fellowship and is board-certified in internal medicine.

Dr. Thompson welcomes patients to Thompson Medical Group, where they can be sure of outstanding care delivered in a professional and respectful environment.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Teodor Pitea, MD

Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.

Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.

In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.

During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.

Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.

Teodor Pitea, MD

Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.

Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.

In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.

During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.

Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/